Related Experiment Video
Updated: May 30, 2026
08:06
The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
Monocyclic β-lactams: new structures for new biological activities
1Department of Chemistry G. Ciamician, University of Bologna, Via Selmi 2, 40126 Bologna, Italy. paola.galletti@unibo.it
Current Medicinal Chemistry
|August 25, 2011
Summary
Monocyclic β-lactams, beyond antibiotics, show diverse biological activities. Structural modifications of these azetidinone derivatives yield novel anticancer, antitubercular, and enzyme inhibitors.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- The azetidinone core, or monocyclic β-lactam, is a versatile scaffold for drug discovery.
- Recent research highlights non-antibacterial pharmacological activities of β-lactam derivatives.
- Structural modifications of the azetidinone ring enable the development of compounds with diverse biological effects.
Purpose of the Study:
- To review recent advancements in the biological activities of monocyclic β-lactam derivatives.
- To explore the structure-activity relationships of azetidinone compounds targeting various enzymes and diseases.
- To highlight the potential of β-lactams as anticancer, antitubercular, and anti-inflammatory agents.
Main Methods:
- Literature review of studies on monocyclic β-lactam synthesis and biological evaluation.
- Analysis of structure-activity relationships based on substituents at the azetidinone ring.
- Compilation of data on enzyme inhibition and therapeutic applications.
Main Results:
- Monocyclic β-lactams exhibit a broad spectrum of biological activities, including anticancer, antitubercular, and enzyme inhibition.
- Compounds targeting hydroxy fatty acid amide hydrolase (HFAAH), histone deacetylase (HDAC), tryptase, Cathepsin K, and vasopressin have been identified.
- Specific structural modifications on the azetidinone ring correlate with distinct pharmacological effects.
Conclusions:
- Monocyclic β-lactams are promising scaffolds for developing novel therapeutics beyond antibacterial agents.
- Targeted structural modifications of the azetidinone core can yield potent inhibitors for various enzymes and disease targets.
- Further research into azetidinone derivatives holds significant potential for drug discovery in oncology, infectious diseases, and inflammation.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...